Pharmacovigilance and Risk Management in 2020: A Global Perspective
With the development of expedited regulatory frameworks in the US, EU, and Japan to address unmet medical needs, traditional clinical safety and pharmacovigilance methods must adapt. The ability to apply best practices in current daily operations while anticipating coming changes associated with new therapies and technologies - against an ever-changing regulatory, political and environmental backdrop - is key to putting safe products on the market and optimizing benefits to patients. Learn more about international and regional initiatives impacting Pharmacovigilance in 2020.
Voluntary guidances, accepted as worldwide best practices, as well as guidelines that are translated into regulation by regional health authorities, continue to play a key role in the advancement of public health.
From all corners of the globe, the focus on and accounting of the risks inherent in the development of therapeutic medical products sharpens – aided by new technologies and a desire for standardized practices, even amidst regulatory complexity, resource allocations, and regional distinctions.
Risk Management in 2020
From updates on shared system REMS to the Harmonisation of RMP Project (HaRP), regulatory authorities continue the work to address and minimize inconsistencies and address safety concerns.
Section 4: Rabbit Hole FAQs
What's a Rabbit Hole?
A rabbit hole is a place you go to see magic things.
Is it Dangerous?
It's only dangerous if you're not prepared to experience exciting things.
Is This Thing Real?
Why don't you come down the rabbit hole and join me. I'll let you decide if it's real.
What If I Don't Go Down?
Well, I can say that you won't have as much of an enjoyable experience as you would otherwise.